Francesco Gentile

Prevalence of valvular regurgitation by Doppler echocardiography in patients with structurally normal hearts by two-dimensional echocardiography.

The prevalence of valvular regurgitation in a large population with structurally normal hearts remains unknown. From the computer database of the echocardiography laboratory of the hospital, 7209 records containing results of both two-dimensional and Doppler echocardiographic examinations were identified, from which 867 (12%) with no structural abnormality on two-dimensional echocardiograms were obtained for analysis. Of these 867 records, 291 (34%) had evidence of regurgitation by Doppler technique in at least one cardiac valve. Mitral regurgitation was found in 167 (19%), tricuspid regurgitation in 151 (17%), pulmonic regurgitation in 45 (5%), and aortic regurgitation in 29 records (3%). Regurgitation of just one valve was the most common and occurred in 207 records (24%). This was followed by regurgitation of two valves (69 records, 8%), three valves (13 records, 2%), and four valves (two records, 0.2%). The prevalence of mitral, tricuspid, and aortic regurgitation was found to increase significantly with increasing age, as was the prevalence of regurgitation involving multiple valves. In 98% and 95% of mitral and tricuspid regurgitations, respectively, the jets were confined to the proximal one fourth of the atria, suggesting only trivial or mild regurgitation. Thus valvular regurgitation occurs not uncommonly in patients with structurally normal hearts referred for echocardiographic evaluation. These findings caution against the inappropriate diagnosis of clinical disease in the many patients who fall into this category. The increasing prevalence of valvular regurgitation with increasing age suggests that a wear-and-tear phenomenon rather than a congenital cause is involved in most instances.

New technologies applied to stress echocardiography: myocardial contrast echocardiography.

The development of new echocardiographic contrast agents that can be injected intravenously and can opacify left-sided cardiac chambers has offered a contribution in the field of stress-echocardiography for two main reasons: (1) the improvement of visualization of the endocardial border and thus facilitating recognition of wall motion abnormalities during pharmacological stress or physical exercise; and (2) the obtaining of information on myocardial perfusion during stress examinations. This review will consider: (1) the improvement of diagnostic accuracy during pharmacological stress or physical exercise obtained with the administration of echo-contrast agents; (2) the results of major studies for comparison of the myocardial contrast echocardiography technique versus single-photon emission computed tomography (SPECT) and coronary angiography; (3) the added value for studying perfusion other than wall motion analysis during stress echo; and (4) the advantages and limitations of different stress modalities. New multicenter studies should now definitively clarify the choice of the best contrast agents and create protocols for myocardial contrast echocardiography using different methods of image acquisition in order to unify the diagnostic process before a ‘label approved’ for perfusion of contrast echocardiographic agents. Finally, caution should be considered when contrast agents are used in the acute phase of myocardial infarction or ischemia.